Related Experiment Video
Updated: Sep 20, 2025

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
[Correlation between Serum G-CSF Level and Immune Function in Children with Aplastic Anemia]
1Department of Pediatric Hematology, Tangshan Maternal & Child Health Hospital, Tangshan 063000, Hebei Province, China,E-mail: eavorforever@163.com.
Insights
Children with aplastic anemia (AA) treated with immunosuppressive therapy (IST) face a higher risk of immune dysfunction. Low serum granulocyte colony-stimulating factor (G-CSF) levels are linked to this dysfunction and can help predict its occurrence.
Area of Science:
- Pediatric Hematology
- Immunology
- Oncology
Background:
- Aplastic anemia (AA) is a rare but serious condition.
- Immunosuppressive therapy (IST) is a common treatment for AA.
- Immune dysfunction can be a complication of IST.
Purpose of the Study:
- To investigate the incidence of immune dysfunction in children with AA post-IST.
- To identify factors contributing to immune dysfunction in these patients.
- To analyze the correlation between granulocyte colony-stimulating factor (G-CSF) levels and immune dysfunction.
Main Methods:
- 34 children with AA received IST for 6 months.
- Patients were divided into groups based on immune dysfunction occurrence post-treatment.
- Serum G-CSF and Interferon-gamma (IFN-γ) levels were measured and compared.
- Regression analysis and ROC curves were used to assess G-CSF's predictive value.
Main Results:
- 35.29% of children developed immune dysfunction after IST.
- The immune dysfunction group had higher IFN-γ and lower G-CSF levels.
- Low G-CSF expression was identified as a significant risk factor for immune dysfunction (OR>1, P<0.05).
- Serum G-CSF demonstrated good predictive value for immune dysfunction (AUC=0.843).
Conclusions:
- Children with AA are at increased risk of immune dysfunction following IST.
- Low serum G-CSF expression is associated with post-IST immune dysfunction in pediatric AA.
- Monitoring serum G-CSF levels may aid in predicting and managing immune dysfunction in these patients.
Objective:
To observe the occurrence of immune dysfunction in children with aplastic anemia (AA) and the factors that may lead to immune dysfunction, analyze the relationship between the expression of granulocyte colony stimulating factor (G-CSF) and immune dysfunction.
Methods:
A total of 34 children with AA treated in our hospital from December 2016 to September 2018 were selected. All the children received immunosuppressive therapy (IST) for 6 months. According to whether the children had immune dysfunction after 6 months of treatment, they were divided into occurrence group and non occurrence group. General information and laboratory indices were compared between the two groups, and serum G-CSF level was tested, the relationship between serum G-CSF level and immune dysfunction in AA children after treatment with IST was observed and analyzed.
Results:
After treatment with IST for 6 months, 12 cases developed immune dysfunction (35.29%). Serum interferon (IFN)-γ level of the occurrence group was higher but G-CSF level was lower than those of the non occurrence group (P<0.05), while the difference of other baseline data was not statistically significant (P>0.05). Multiple regression analysis showed that overexpression of serum IFN-γ and low expression of G-CSF were both the influencing factors of immune dysfunction in AA children after IST treatment (OR>1, P<0.05). ROC curve was drawn, and the result showed that the area under the curve (AUC) of serum G-CSF level predicted the risk of immune dysfunction after IST was 0.843>0.80, when the index cut-off value was set at 6.614 pg/ml, the predictive value was ideal.
Conclusion:
AA children have a higher risk of immune dysfunction after IST, which may be related to the low expression of serum G-CSF. The detection of serum G-CSF expression can be considered to predict the risk of immune dysfunction in AA children after IST, so as to guide early clinical intervention.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

